Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U1HE
|
||||
| Former ID |
DIB015493
|
||||
| Drug Name |
PEGylated PYY-3-36
|
||||
| Synonyms |
PEG-PYY; PEGylated PYY-3-36, Roche
|
||||
| Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Investigative | [543757] | ||
| Company |
Hoffmann-La Roche Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Neuropeptide Y receptor type 2 | Target Info | Modulator | [543757] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

